These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 15563600)

  • 1. Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas.
    Colnot S; Decaens T; Niwa-Kawakita M; Godard C; Hamard G; Kahn A; Giovannini M; Perret C
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17216-21. PubMed ID: 15563600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin.
    Harada N; Miyoshi H; Murai N; Oshima H; Tamai Y; Oshima M; Taketo MM
    Cancer Res; 2002 Apr; 62(7):1971-7. PubMed ID: 11929813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver.
    Ovejero C; Cavard C; Périanin A; Hakvoort T; Vermeulen J; Godard C; Fabre M; Chafey P; Suzuki K; Romagnolo B; Yamagoe S; Perret C
    Hepatology; 2004 Jul; 40(1):167-76. PubMed ID: 15239100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
    Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
    Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor promotion and inhibition by phenobarbital in livers of conditional Apc-deficient mice.
    Braeuning A; Gavrilov A; Geissler M; Wenz C; Colnot S; Templin MF; Metzger U; Römer M; Zell A; Schwarz M
    Arch Toxicol; 2016 Jun; 90(6):1481-94. PubMed ID: 26838046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperation Between MYC and β-Catenin in Liver Tumorigenesis Requires Yap/Taz.
    Bisso A; Filipuzzi M; Gamarra Figueroa GP; Brumana G; Biagioni F; Doni M; Ceccotti G; Tanaskovic N; Morelli MJ; Pendino V; Chiacchiera F; Pasini D; Olivero D; Campaner S; Sabò A; Amati B
    Hepatology; 2020 Oct; 72(4):1430-1443. PubMed ID: 31965581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
    Calvisi DF; Factor VM; Loi R; Thorgeirsson SS
    Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin.
    Sekiya T; Nakamura T; Kazuki Y; Oshimura M; Kohu K; Tago K; Ohwada S; Akiyama T
    Cancer Res; 2002 Jun; 62(11):3322-6. PubMed ID: 12036951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism.
    Cadoret A; Ovejero C; Terris B; Souil E; Lévy L; Lamers WH; Kitajewski J; Kahn A; Perret C
    Oncogene; 2002 Nov; 21(54):8293-301. PubMed ID: 12447692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditional disruption of Axin1 leads to development of liver tumors in mice.
    Feng GJ; Cotta W; Wei XQ; Poetz O; Evans R; Jardé T; Reed K; Meniel V; Williams GT; Clarke AR; Dale TC
    Gastroenterology; 2012 Dec; 143(6):1650-9. PubMed ID: 22960659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
    Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
    Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apc tumor suppressor gene is the "zonation-keeper" of mouse liver.
    Benhamouche S; Decaens T; Godard C; Chambrey R; Rickman DS; Moinard C; Vasseur-Cognet M; Kuo CJ; Kahn A; Perret C; Colnot S
    Dev Cell; 2006 Jun; 10(6):759-70. PubMed ID: 16740478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling.
    Kielman MF; Rindapää M; Gaspar C; van Poppel N; Breukel C; van Leeuwen S; Taketo MM; Roberts S; Smits R; Fodde R
    Nat Genet; 2002 Dec; 32(4):594-605. PubMed ID: 12426568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer.
    Calvisi DF; Conner EA; Ladu S; Lemmer ER; Factor VM; Thorgeirsson SS
    J Hepatol; 2005 Jun; 42(6):842-9. PubMed ID: 15885355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing.
    Yau TO; Chan CY; Chan KL; Lee MF; Wong CM; Fan ST; Ng IO
    Oncogene; 2005 Feb; 24(9):1607-14. PubMed ID: 15580286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells.
    Roh H; Green DW; Boswell CB; Pippin JA; Drebin JA
    Cancer Res; 2001 Sep; 61(17):6563-8. PubMed ID: 11522655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas.
    Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T
    Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
    Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
    Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcription factor c-Jun protects against liver damage following activated β-Catenin signaling.
    Trierweiler C; Blum HE; Hasselblatt P
    PLoS One; 2012; 7(7):e40638. PubMed ID: 22792392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.